Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M

Cidara Therapeutics reports 2023 executive compensation

By ExecPay News

Published: June 3, 2024

Cidara Therapeutics reported fiscal year 2023 executive compensation information on June 3, 2024.
In 2023, three executives at Cidara Therapeutics received on average a compensation package of $1.1M, a 26% increase compared to previous year.
Average pay of disclosed executives at Cidara Therapeutics
Jeffrey Stein, Chief Executive Officer, received $1.6M in total, which increased by 24% compared to 2022. 38% of Stein's compensation, or $594K, was in salary. Stein also received $292K in non-equity incentive plan, $388K in option awards, $274K in stock awards, as well as $9.9K in other compensation.
Shane Ward, Chief Operating Officer, received a compensation package of $930K. 49% of the compensation package, or $455K, was in salary.
Taylor Sandison, Chief Medical Officer, earned $884K in 2023, a 22% increase compared to previous year.

Related executives

Jeffrey Stein

Cidara Therapeutics

Chief Executive Officer

Taylor Sandison

Cidara Therapeutics

Chief Medical Officer

Shane Ward

Cidara Therapeutics

Chief Operating Officer

You may also like

Source: SEC filing on June 3, 2024.